SCHEDULE 14A

Company

Lexaria Bioscience Corp.

Filed

May 20, 2014

Period of Report

June 11, 2014

Accession Number

0001062993-14-003195

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →